These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24810239)

  • 1. Synthesis, characterization and mechanistic-insight into the anti-proliferative potential of PLGA-gemcitabine conjugate.
    Khare V; Kour S; Alam N; Dubey RD; Saneja A; Koul M; Gupta AP; Singh D; Singh SK; Saxena AK; Gupta PN
    Int J Pharm; 2014 Aug; 470(1-2):51-62. PubMed ID: 24810239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy.
    Khare V; Singh A; Mahajan G; Alam N; Kour S; Gupta M; Kumar A; Singh G; Singh SK; Saxena AK; Mondhe DM; Gupta PN
    Eur J Pharm Sci; 2016 Sep; 92():183-93. PubMed ID: 27404580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
    Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
    Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine loaded biodegradable PLGA nanospheres for in vitro pancreatic cancer therapy.
    Jaidev LR; Krishnan UM; Sethuraman S
    Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():40-7. PubMed ID: 25492170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabine.
    Dubey RD; Alam N; Saneja A; Khare V; Kumar A; Vaidh S; Mahajan G; Sharma PR; Singh SK; Mondhe DM; Gupta PN
    Int J Pharm; 2015 Aug; 492(1-2):80-91. PubMed ID: 26165611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine-based therapy for pancreatic cancer using the squalenoyl nucleoside monophosphate nanoassemblies.
    Maksimenko A; Caron J; Mougin J; Desmaële D; Couvreur P
    Int J Pharm; 2015 Mar; 482(1-2):38-46. PubMed ID: 25448549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery.
    Joshi G; Kumar A; Sawant K
    Eur J Pharm Sci; 2014 Aug; 60():80-9. PubMed ID: 24810394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial and sequential delivery of gemcitabine and oseltamivir phosphate from implantable poly(d,l-lactic-co-glycolic acid) cylinders disables human pancreatic cancer cell survival.
    Allison Logan S; Brissenden AJ; Szewczuk MR; Neufeld RJ
    Drug Des Devel Ther; 2017; 11():2239-2250. PubMed ID: 28814832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells.
    Papa AL; Basu S; Sengupta P; Banerjee D; Sengupta S; Harfouche R
    BMC Cancer; 2012 Sep; 12():419. PubMed ID: 22998550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a stability indicating isocratic HPLC method for gemcitabine with application to drug release from poly lactic-co-glycolic acid nanoparticles and enzymatic degradation studies.
    Chen G; Svirskis D; Wen J
    J Pharm Pharmacol; 2015 Nov; 67(11):1528-36. PubMed ID: 26369422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatible gemcitabine-based nanomedicine engineered by Flow Focusing for efficient antitumor activity.
    Martín-Banderas L; Sáez-Fernández E; Holgado MÁ; Durán-Lobato MM; Prados JC; Melguizo C; Arias JL
    Int J Pharm; 2013 Feb; 443(1-2):103-9. PubMed ID: 23299085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs) using central composite design.
    Yalcin TE; Ilbasmis-Tamer S; Takka S
    Int J Pharm; 2018 Sep; 548(1):255-262. PubMed ID: 29969712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies.
    Khan AM; Ahmad FJ; Panda AK; Talegaonkar S
    Int J Pharm; 2016 Jun; 507(1-2):61-71. PubMed ID: 27154254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR targeted PLGA nanoparticles using gemcitabine for treatment of pancreatic cancer.
    Aggarwal S; Yadav S; Gupta S
    J Biomed Nanotechnol; 2011 Feb; 7(1):137-8. PubMed ID: 21485840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations.
    Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S
    Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic targeting/prodrug strategies for intravesical drug delivery--lectin-modified PLGA microparticles enhance cytotoxicity of stearoyl gemcitabine by contact-dependent transfer.
    Neutsch L; Wirth EM; Spijker S; Pichl C; Kählig H; Gabor F; Wirth M
    J Control Release; 2013 Jul; 169(1-2):62-72. PubMed ID: 23588390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topotecan-tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential.
    Khuroo T; Verma D; Talegaonkar S; Padhi S; Panda AK; Iqbal Z
    Int J Pharm; 2014 Oct; 473(1-2):384-94. PubMed ID: 25051112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BSA-PLGA-based core-shell nanoparticles as carrier system for water-soluble drugs.
    Chitkara D; Kumar N
    Pharm Res; 2013 Sep; 30(9):2396-409. PubMed ID: 23756758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors.
    Bhatnagar P; Kumari M; Pahuja R; Pant AB; Shukla Y; Kumar P; Gupta KC
    Drug Deliv Transl Res; 2018 Jun; 8(3):565-579. PubMed ID: 29441466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin conjugated with PLGA potentiates sustainability, anti-proliferative activity and apoptosis in human colon carcinoma cells.
    Waghela BN; Sharma A; Dhumale S; Pandey SM; Pathak C
    PLoS One; 2015; 10(2):e0117526. PubMed ID: 25692854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.